Advertisement

Topic - Gw Pharmaceuticals

Related Stories

In this April 23, 2018, photo, Meagan Patrick kisses her daughter, Addelyn Patrick, 5, in the playroom at Realm of Caring in Colorado Springs, Colo. Addelyn was born with a brain malformation and suffers from multiple forms of seizures. The U.S. Food and Drug Administration is expected to decide soon whether to give its first approval to a prescription drug made from the marijuana plant. But parents, including Meagan, who have used other products containing chemicals from the plant to treat their children’s severe forms of epilepsy are feeling more cautious than celebratory. (AP Photo/Thomas Peipert)

U.S. could back 1st marijuana-derived medicine, and some are worried

By Kathleen Foody and P. Solomon Banda - Associated Press

FILE - This May 23, 2017 file photo shows GW Pharmaceuticals’ Epidiolex, a medicine made from the marijuana plant but without THC. On Thursday, April 19, 2018, a panel of Food and Drug Administration health advisers recommended approval of the drug, moving the closely watched medication closer to the U.S. market. (AP Photo/Kathy Young, File)

US experts back marijuana-based drug for childhood seizures

By MATTHEW PERRONE - Associated Press

FILE - This May 23, 2017, file photo shows GW Pharmaceuticals’ Epidiolex, a medicine made from the marijuana plant but without TCH. The medicine reduced seizures in children with severe forms of epilepsy and warrants approval in the United States, health officials said Tuesday, April 17, 2018. (AP Photo/Kathy Young, File)

Marijuana-based drug gets positive review from US agency

By MATTHEW PERRONE - Associated Press

Ga. moves forward on medicinal marijuana study

Associated Press